Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Jeffrey Stein Insider Profile
25 Followers
Jeffrey Stein, President & CEO, Director at Cidara Therapeutics, holds 1.53M shares in Cidara Therapeutics (Ticker: CDTX), holds 0.00 shares in Paratek Pharmaceuticals (Ticker: PRTK), holds ― shares in IDEAYA Biosciences (Ticker: IDYA).
Jeffrey Stein Cidara Therapeutics (CDTX)President & CEO, Director
Cidara Therapeutics (CDTX)
President & CEO, Director
Ranked #87,792 out of 98,501 Corporate Insiders
Profitable Transactions
1 out of 10 Profitable Transactions
Average Return
-22.80%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Jeffrey Stein holds in companies
Most Profitable Insider Trade
Stock:
Rating:Informative Buy
Date:Sep 26, 2019 - Sep 26, 2020
Return:+63.30%
The most profitable trade made by Jeffrey Stein
Jeffrey Stein's Trading History
Cidara Therapeutics
Mar 12, 2024
President & CEO, Director
Uninformative Sell
39.12K
$1.10M
Paratek Pharmaceuticals
Sep 21, 2023
―
Uninformative Sell
―
$0.00
IDEAYA Biosciences
―
Director
―
―
Trius Therap
Aug 02, 2010
―
Uninformative Buy
―
―
List of latest transactions for each holding click on a transaction to see Jeffrey Stein's performance on stock
You May Also Like
Jeffrey Stein insider profile FAQ
What is the percentage of profitable transactions made by Jeffrey Stein?
The percentage of profitable transactions made by Jeffrey Stein is 10%.
What is the average return per transaction made by Jeffrey Stein?
The average return per transaction made by Jeffrey Stein is -22.80%.
What stocks does Jeffrey Stein hold?
Jeffrey Stein holds: CDTX, PRTK, IDYA, TSRX stocks.
What was Jeffrey Stein’s latest transaction?
Jeffrey Stein latest transaction was an Uninformative Sell of $39.12K.
What was Jeffrey Stein's most profitable transaction?
Jeffrey Stein’s most profitable transaction was an Informative Buy of CDTX stock on September 26, 2019. The return on the trade was 63.30%.
What is Jeffrey Stein's role in Cidara Therapeutics?
Jeffrey Stein's role in Cidara Therapeutics is President & CEO, Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.